126 related articles for article (PubMed ID: 1848069)
1. Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.
Bishop SA; Hill TJ
Arch Virol; 1991; 116(1-4):57-68. PubMed ID: 1848069
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus infection and damage in the central nervous system: immune response to myelin basic protein.
Bishop SA; Hill TJ
J Neurol Sci; 1989 Jun; 91(1-2):109-18. PubMed ID: 2473169
[TBL] [Abstract][Full Text] [Related]
3. Invasion of the central nervous system by herpes simplex virus type 1 after subcutaneous inoculation of immunosuppressed mice.
Oakes JE
J Infect Dis; 1975 Jan; 131(1):51-7. PubMed ID: 162925
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system infection and immune response in mice inoculated into the lip with herpes simplex virus type 1.
Kastrukoff L; Hamada T; Schumacher U; Long C; Doherty PC; Koprowski H
J Neuroimmunol; 1982 Jun; 2(3-4):295-305. PubMed ID: 6282930
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological characterisation of acute herpes simplex virus infection of lumbar dorsal root ganglia in the rat.
Blondeau JM; Aoki FY; Nagy JI
J Med Microbiol; 1993 Apr; 38(4):265-9. PubMed ID: 8386252
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
7. Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance.
Altmann DM; Blyth WA
J Gen Virol; 1985 Jun; 66 ( Pt 6)():1297-303. PubMed ID: 3159847
[TBL] [Abstract][Full Text] [Related]
8. The influence of androgens on paralysis in mice following intravenous inoculation of herpes simplex virus.
Yirrell DL; Blyth WA; Hill TJ
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2461-4. PubMed ID: 2821183
[TBL] [Abstract][Full Text] [Related]
9. The effects of dietary T-2 toxin on acute herpes simplex virus type 1 infection in mice.
Friend SC; Schiefer HB; Babiuk LA
Vet Pathol; 1983 Nov; 20(6):737-60. PubMed ID: 6649341
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex.
Altmann DM; Blyth WA
Immunology; 1984 Nov; 53(3):473-80. PubMed ID: 6092271
[TBL] [Abstract][Full Text] [Related]
11. The relationship of astrocytes and macrophages to CNS demyelination after experimental herpes simplex virus infection.
Townsend JJ
J Neuropathol Exp Neurol; 1981 Jul; 40(4):369-79. PubMed ID: 7252523
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 infection and immunity in immunosuppressed mice.
Litwińska B; Sadowski W; Kańtoch M
Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of subviral herpes simplex virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses.
Slichtová V; Kutinová L; Vonka V
Arch Virol; 1980; 66(3):207-14. PubMed ID: 6255896
[TBL] [Abstract][Full Text] [Related]
14. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
Townsend JJ; Baringer JR
Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
[TBL] [Abstract][Full Text] [Related]
15. Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier.
McKendall RR
J Gen Virol; 1983 Sep; 64 (Pt 9)():1965-72. PubMed ID: 6310036
[TBL] [Abstract][Full Text] [Related]
16. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
Quenelle DC; Collins DJ; Marciani DJ; Kern ER
Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820
[TBL] [Abstract][Full Text] [Related]
17. Intra-axonal virus in demyelinative lesions of experimental herpes simplex type 2 infection.
Martin JR
J Neurol Sci; 1984 Jan; 63(1):63-74. PubMed ID: 6321668
[TBL] [Abstract][Full Text] [Related]
18. Herpes virus reactivation in a mouse model.
Hurd J; Robinson TW
J Antimicrob Chemother; 1977 Mar; 3 Suppl A():99-106. PubMed ID: 193826
[No Abstract] [Full Text] [Related]
19. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection.
Armerding D; Scriba M; Hren A; Rossiter H
Antiviral Res; 1982 May; 2(1-2):3-11. PubMed ID: 6980627
[TBL] [Abstract][Full Text] [Related]
20. Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.
Thomson AW; McPhee CA; Sewell HF
Immunology; 1988 Mar; 63(3):477-82. PubMed ID: 3350582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
